In the U.S., Hispanic women have been disproportionately affected by the HIV epidemic in recent years. Yet they’ve been less likely to take advantage of PrEP, a medication that significantly ...

Samantha Finnie - Mission Prep Teen Treatment, Treatment Center, Rolling Hills Estates, CA, 90274, (424) 250-1072, Mission Prep California provides residential care for teens aged 13-17 struggling ...

The twice-yearly shot lenacapavir, sold under the name Yeztugo, reportedly nearly eliminated new HIV infections in studies of ...

With the FDA’s much-anticipated nod for Gilead Sciences’ long-acting HIV pre-exposure prophylaxis (PrEP) injection Yeztugo (lenacapavir), a new era of HIV prevention has dawned. | The FDA signed off ...

Since the approval of the first PrEP treatment in 2012—also developed by Gilead—usage has remained stubbornly low. According to the Centers for Disease Control and Prevention, ...

The double-blind, multicenter, randomized PURPOSE 2 study evaluated the safety and efficacy of twice-yearly subcutaneous lenacapavir for PrEP compared to once-daily oral Truvada and bHIV in over 3,200 ...

In the U.S., Hispanic women have been disproportionately affected by the HIV epidemic in recent years. Yet they’ve been less likely to take advantage of PrEP, a medication that significantly ...